The impact of ambrisentan and tadalafil upfront combination therapy on cardiac function in scleroderma associated pulmonary arterial hypertension patients: cardiac magnetic resonance feature tracking study

The aim of this study was to evaluate the effect of upfront combination therapy with ambrisentan and tadalafil on left ventricular (LV) and right ventricular (RV) function in patients with systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH). LV and RV peak longitudinal and circum...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Takahiro, Ambale-Venkatesh, Bharath, Lima, Joao A.C., Zimmerman, Stefan L., Tedford, Ryan J., Fujii, Tomoki, Hulme, Olivia L., Pullins, Erica H., Corona-Villalobos, Celia P., Zamanian, Roham T., Minai, Omar A., Girgis, Reda E., Chin, Kelly, Khair, Rubina, Damico, Rachel L., Kolb, Todd M., Mathai, Stephen C., Hassoun, Paul M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018906/
https://www.ncbi.nlm.nih.gov/pubmed/29251556
http://dx.doi.org/10.1177/2045893217748307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018906/
https://www.ncbi.nlm.nih.gov/pubmed/29251556
http://dx.doi.org/10.1177/2045893217748307

Ejemplares similares